跳至主要内容
临床试验/ISRCTN97767916
ISRCTN97767916已完成不适用

Randomised trial in newly diagnosed Hodgkin's disease: evaluation of drug scheduling (alternating LOPP/EVAP versus LOPP/EVA hybrid) and consolidation radiotherapy

Cancer Research UK (CRUK) (UK)0 个研究点目标入组 0 人开始时间: 2001年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged over 15 years
  • 2. Stage IB, IIB, III or IV Hodgkin's Disease.
  • 3. Histologically confirmed Hodgkin's lymphoma
  • 4. Free from any potentially life threatening disease other than Hodgkin's Disease
  • 5. Lymphangiography or Computed Tomography (CT) scan of the abdomen
  • 6. No previous treatment except as an emergency measure

排除标准

  • Not provided at time of registration

研究者

发起方
Cancer Research UK (CRUK) (UK)

相似试验

Randomised trial in newly diagnosed Hodgkin's... | 临床试验